Gracilins: Spongionella-derived promising compounds for Alzheimer disease.
about
New Drugs from Marine Organisms in Alzheimer's DiseaseDevelopment and Structural Modification of BACE1 InhibitorsMultiple signaling factors and drugs alleviate neuronal death induced by expression of human and zebrafish tau proteins in vivoNrf2--a therapeutic target for the treatment of neurodegenerative diseases.Spongionella Secondary Metabolites, Promising Modulators of Immune Response through CD147 Receptor Modulation.Tempol and perindopril protect against lipopolysaccharide-induced cognition impairment and amyloidogenesis by modulating brain-derived neurotropic factor, neuroinflammation and oxido-nitrosative stress.The Potential of Indonesian Heterobranchs Found around Bunaken Island for the Production of Bioactive Compounds.Evaluation of the Protective Effects of Sarains on H2O2-Induced Mitochondrial Dysfunction and Oxidative Stress in SH-SY5Y Neuroblastoma Cells.Rhinacanthin C Alleviates Amyloid-β Fibrils' Toxicity on Neurons and Attenuates Neuroinflammation Triggered by LPS, Amyloid-β, and Interferon-γ in Glial Cells.Photoinduced Cycloadditions in the Diversity-Oriented Synthesis Toolbox: Increasing Complexity with Straightforward Postphotochemical Modifications.Protective effects of telmisartan and tempol on lipopolysaccharide-induced cognitive impairment, neuroinflammation, and amyloidogenesis: possible role of brain-derived neurotrophic factor.Cytotoxic Spiroepoxide Lactone and Its Putative Biosynthetic Precursor from Goniobranchus Splendidus.Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds
P2860
Q26771804-369CF4A3-792B-4208-9114-AD5E7110795DQ28068099-9F4CA7E3-5975-45CF-8E93-85051E6D895DQ28386141-92E2E708-AB31-4557-96BB-97D167592E3DQ36732766-488B204D-3D09-462A-9468-6ED573E6961FQ41542867-8FEF8D19-F7AC-4166-89A3-5CCF1C92FBD9Q46243411-C462B7AF-BE8B-449E-B8C6-AEC68B807461Q46246075-60616534-3E85-4725-9831-BC83CB1ED3B8Q46370532-0083E57D-F5BE-43BF-B46C-AD0E6FB7A900Q47104106-8A676605-0BEF-467C-8119-BB037577FFC8Q47115782-22EA3E46-75CE-45F5-9563-F1BF21214C6FQ50211325-F8C3E020-8273-423F-9645-DE8483C54998Q55689321-D0914F11-9EDD-4BD8-A41E-3B349621161BQ58764243-5BA3BBCA-7C66-456F-A0BB-53B354B5DB09
P2860
Gracilins: Spongionella-derived promising compounds for Alzheimer disease.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Gracilins: Spongionella-derived promising compounds for Alzheimer disease.
@en
type
label
Gracilins: Spongionella-derived promising compounds for Alzheimer disease.
@en
prefLabel
Gracilins: Spongionella-derived promising compounds for Alzheimer disease.
@en
P2093
P50
P1433
P1476
Gracilins: Spongionella-derived promising compounds for Alzheimer disease.
@en
P2093
Amparo Alfonso
Luis M Botana
Marta Leirós
Mostafa E Rateb
Rainer Ebel
P304
P356
10.1016/J.NEUROPHARM.2015.02.015
P577
2015-02-24T00:00:00Z